SCLX Q4 2021 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

Q4 2021 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$8M+40.3% YoY

Gross Profit

$7M86.9% margin

Operating Income

-$10M-126.1% margin

Net Income

-$42M-507.9% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

-0.7%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$28M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$78M

Total Liabilities

$302M

Stockholders' Equity

-$224M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$6M	+40.3%
Gross Profit	$7M	$5M	+34.1%
Operating Income	-$10M	-$9M	-18.2%
Net Income	-$42M	-$12M	-253.2%